DB12173

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 2020
gptkbp:ATCCode J05AB16
gptkbp:bioavailability low (prodrug)
gptkbp:blackBoxWarning No
gptkbp:CASNumber 1809249-37-3
gptkbp:contraindication hypersensitivity to remdesivir
gptkbp:drugClass antiviral drug
gptkbp:drugInteraction chloroquine
hydroxychloroquine
gptkbp:eliminatedIn renal
gptkbp:eliminationHalfLife 1 hour (remdesivir), 25 hours (GS-441524)
gptkbp:form solution for infusion
gptkbp:hasBoxedWarning No
gptkbp:hasDrugType small molecule
gptkbp:hasInChIKey RWWYLEGWBNMMLJ-YSOARWBDSA-N
gptkbp:hasMolecularFormula C27H35N6O8P
gptkbp:hasPatentHolder gptkb:Gilead_Sciences
gptkbp:hasPharmacokinetics prodrug, rapidly metabolized to active nucleoside analog
gptkbp:hasPregnancyCategoryAU gptkb:B3
gptkbp:hasPregnancyCategoryUS Not assigned
gptkbp:hasSMILES CC(C)[C@@H](NC(=O)[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O)P(=O)(OCCO)OCCO
gptkbp:hasStorageRequirements refrigerated
gptkbp:hasUNII 0N1J5A44B2
https://www.w3.org/2000/01/rdf-schema#label DB12173
gptkbp:indication gptkb:COVID-19
gptkb:Ebola_virus_infection_(investigational)
gptkbp:legalStatus prescription only
gptkbp:manufacturer gptkb:Gilead_Sciences
gptkbp:mechanismOfAction RNA-dependent RNA polymerase inhibitor
gptkbp:metabolism liver
gptkbp:molecularWeight 602.6 g/mol
gptkbp:name gptkb:Remdesivir
gptkbp:pregnancyCategory Not assigned
gptkbp:PubChem_CID gptkb:DB12173
121304016
58828033
CHEMBL2016761
D11472
gptkbp:routeOfAdministration intravenous
gptkbp:sideEffect nausea
elevated liver enzymes
hypersensitivity
gptkbp:status FDA approved
EMA approved
gptkbp:synonym gptkb:Veklury
gptkb:GS-5734
gptkbp:target RNA-dependent RNA polymerase
gptkbp:bfsParent gptkb:Lorlatinib
gptkbp:bfsLayer 7